资讯
内科
心血管
肿瘤
内分泌
普通内科
消化
呼吸
神经科
传染科
精神心理
肾内科
风湿免疫
血液科
老年医学
外科
头颈外科
胃肠外科
血管外科
肝胆胰外
骨科
普通外科
胸心外科
神经外科
泌尿外科
烧伤科
整形美容
麻醉疼痛
专科科室
罕见病
康复医学
药械
儿科
耳鼻咽喉
口腔科
眼科
政策人文
营养全科
预防公卫
妇产科
中医科
急重症
皮肤性病
影像放射
转化医学
检验病理
护理
热点
临床研究
研究设计
人工智能
智慧医疗
论文基金
医学科普
药物经济
医生集团
职业安全
患者招募
医学科研
公司产业
医学英语
MedSci动态
指南
按科室浏览
肿瘤科
心血管
传染科
妇产科
神经科
儿科
呼吸
内分泌科
血液科
消化
更多科室
工具
临床工具
临床指南
医学计算与公式
ICD-10/ICD-11疾病编码
医讯达
直播
话题
公开课
精品课
科研工具
期刊数据库查询
期刊智能选择
全球基金查询
文献查询
SCI写作宝典
生物医药大词典
其他工具
下载App使用方便更快捷
Medsci 梅斯搜索
公开课
精品课
服务
科研数智化
直播,公开课与精品课
科研加速器
研究者发起的临床研究(IIS)支持
真实世界研究解决方案
药物经济学
医保准入事务
研究方案设计
数据库建立与管理
药物警戒(PV)
真实世界研究执行
数据统计分析
数字化学术传播解决方案
多渠道营销(MCM)
产品医学策略
学术传播(APO)
其它
积分商城
FAQS
#评价#
750篇内容 | 2992人围观
关注话题
话题活跃用户
#
插入话题
插入图片
评论
最新
最热
GetTopicDetailResponse(id=3d9291459d1, topicName=评价, introduction=评价, content=null, image=null, comments=750, allHits=2992, url=https://h5.medsci.cn/topic?id=91459, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=6980, tagList=[TagDto(tagId=6980, tagName=评价)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1444452, encodeId=ce09144445261, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=带量采购结果公布,过一致性评价药品命中率高,重点监控品种暂停交易, objectType=article, longId=153492, objectId=54f715349287, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=54f715349287, replyNumber=0, likeNumber=72, createdTime=2018-11-15, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=54f715349287, moduleTitle=带量采购结果公布,过一致性评价药品命中率高,重点监控品种暂停交易, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=54f715349287)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444451, encodeId=e319144445175, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=不通过一致性评价注销批文?江苏药监**回应来了, objectType=article, longId=153061, objectId=7c19153061c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c19153061c3, replyNumber=0, likeNumber=53, createdTime=2018-11-10, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c19153061c3, moduleTitle=不通过一致性评价注销批文?江苏药监**回应来了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c19153061c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444450, encodeId=047c1444450eb, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=Sci Rep:建立三维胶原模型用于磁共振成骨的体外评价, objectType=article, longId=153059, objectId=586f153059e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=586f153059e7, replyNumber=0, likeNumber=48, createdTime=2018-11-10, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=586f153059e7, moduleTitle=Sci Rep:建立三维胶原模型用于磁共振成骨的体外评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=586f153059e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444449, encodeId=7a441444449b5, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=官方发文:未过一致性评价,注销批文!, objectType=article, longId=152954, objectId=3cd61529548c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3cd61529548c, replyNumber=0, likeNumber=84, createdTime=2018-11-08, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3cd61529548c, moduleTitle=官方发文:未过一致性评价,注销批文!, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3cd61529548c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444448, encodeId=071b1444448fe, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=临床药物综合评价应优先开展, objectType=article, longId=152841, objectId=056a15284131, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=056a15284131, replyNumber=0, likeNumber=15, createdTime=2018-11-07, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=056a15284131, moduleTitle=临床药物综合评价应优先开展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=056a15284131)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444447, encodeId=b2bb144444e51, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=Radiology:利用MR指纹识别评价内侧颞叶癫痫病灶的价值, objectType=article, longId=152753, objectId=b54c152e53f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b54c152e53f4, replyNumber=0, likeNumber=97, createdTime=2018-11-06, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b54c152e53f4, moduleTitle=Radiology:利用MR指纹识别评价内侧颞叶癫痫病灶的价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b54c152e53f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444446, encodeId=8cd81444446f2, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=FDA仿制药一致性评价指导原则, objectType=article, longId=152545, objectId=dd1715254575, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd1715254575, replyNumber=0, likeNumber=91, createdTime=2018-11-03, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd1715254575, moduleTitle=FDA仿制药一致性评价指导原则, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd1715254575)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444445, encodeId=2c14144444591, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=NMPA关于仿制药一致性评价的52个细节答疑, objectType=article, longId=152508, objectId=9db51525084a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9db51525084a, replyNumber=0, likeNumber=126, createdTime=2018-11-03, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9db51525084a, moduleTitle=NMPA关于仿制药一致性评价的52个细节答疑, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9db51525084a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444444, encodeId=7d041444444d2, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=NEJM:Hu5F9-G4和利妥昔单抗联合阻断非霍奇金淋巴瘤中CD47的疗效评价, objectType=article, longId=152500, objectId=897a152500bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=897a152500bf, replyNumber=0, likeNumber=72, createdTime=2018-11-02, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=897a152500bf, moduleTitle=NEJM:Hu5F9-G4和利妥昔单抗联合阻断非霍奇金淋巴瘤中CD47的疗效评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=897a152500bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444443, encodeId=1ef11444443b5, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=Anesth Analg:比较患者自控和医师控制丙泊酚镇痛的效果:系统评价和试验序贯的meta分析, objectType=article, longId=152485, objectId=5c4e152485d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c4e152485d0, replyNumber=0, likeNumber=71, createdTime=2018-11-02, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c4e152485d0, moduleTitle=Anesth Analg:比较患者自控和医师控制丙泊酚镇痛的效果:系统评价和试验序贯的meta分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c4e152485d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444442, encodeId=9ce2144444241, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=仿制药通过评价仅仅是补考及格,不要让一致性评价结果变味, objectType=article, longId=151663, objectId=ed8415166360, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed8415166360, replyNumber=0, likeNumber=62, createdTime=2018-10-24, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed8415166360, moduleTitle=仿制药通过评价仅仅是补考及格,不要让一致性评价结果变味, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed8415166360)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444441, encodeId=656f144444194, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=日本仿制药一致性评价,地震后行业巨大提升, objectType=article, longId=151611, objectId=978715161142, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=978715161142, replyNumber=0, likeNumber=72, createdTime=2018-10-24, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=978715161142, moduleTitle=日本仿制药一致性评价,地震后行业巨大提升, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=978715161142)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444440, encodeId=3abd1444440c6, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=Surv Ophthalmol:系统评价营养补充对青光眼的辅助治疗疗效, objectType=article, longId=151542, objectId=2bb71515422e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2bb71515422e, replyNumber=0, likeNumber=76, createdTime=2018-10-23, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2bb71515422e, moduleTitle=Surv Ophthalmol:系统评价营养补充对青光眼的辅助治疗疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2bb71515422e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444439, encodeId=0a1b144443905, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=又一省发文,未过一致性评价不采购, objectType=article, longId=150853, objectId=5d4c1508539b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d4c1508539b, replyNumber=0, likeNumber=73, createdTime=2018-10-13, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d4c1508539b, moduleTitle=又一省发文,未过一致性评价不采购, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d4c1508539b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444438, encodeId=6dbb14444384e, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=Int J Oral Max Surg:HIV阳性患者种植体存活情况的评价, objectType=article, longId=150621, objectId=355e15062118, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=355e15062118, replyNumber=0, likeNumber=58, createdTime=2018-10-10, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=355e15062118, moduleTitle=Int J Oral Max Surg:HIV阳性患者种植体存活情况的评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=355e15062118)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444437, encodeId=73ce144443ee4, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=J Periodontol:腭黏膜移植术后使用氟比洛芬喷雾剂的效果评价, objectType=article, longId=150392, objectId=6f1c15039278, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f1c15039278, replyNumber=0, likeNumber=57, createdTime=2018-10-07, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f1c15039278, moduleTitle=J Periodontol:腭黏膜移植术后使用氟比洛芬喷雾剂的效果评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f1c15039278)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444436, encodeId=aefa1444436ce, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=一致性评价大限将至,新通知昨天出来了!, objectType=article, longId=150120, objectId=cf091501206a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf091501206a, replyNumber=0, likeNumber=57, createdTime=2018-10-02, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf091501206a, moduleTitle=一致性评价大限将至,新通知昨天出来了!, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf091501206a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444435, encodeId=399814444352a, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=碾压原研?过一致性评价仿制药还有这三道坎, objectType=article, longId=150008, objectId=ba4f1500089e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba4f1500089e, replyNumber=0, likeNumber=72, createdTime=2018-10-01, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba4f1500089e, moduleTitle=碾压原研?过一致性评价仿制药还有这三道坎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba4f1500089e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444434, encodeId=a3e414444348c, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=J Periodontol:家族性地中海热和慢性牙周炎患者唾液氧化应激的评价, objectType=article, longId=149636, objectId=da65149636ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da65149636ab, replyNumber=0, likeNumber=63, createdTime=2018-09-27, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da65149636ab, moduleTitle=J Periodontol:家族性地中海热和慢性牙周炎患者唾液氧化应激的评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=da65149636ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1444433, encodeId=54ec14444336b, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, objectTitle=Daiichi宣布开展临床试验:评价其在研抗体偶联药物和Keytruda联合治疗乳腺癌和肺癌的药效, objectType=article, longId=149488, objectId=4ea8149488e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ea8149488e4, replyNumber=0, likeNumber=58, createdTime=2018-09-25, rootId=0, userName=huagfeg, userId=1fee5134542, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ea8149488e4, moduleTitle=Daiichi宣布开展临床试验:评价其在研抗体偶联药物和Keytruda联合治疗乳腺癌和肺癌的药效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ea8149488e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯话题小助手
关注
已关注
评价
2020-05-29
huagfeg
(审核中...)
关注
已关注
前往app查看评论内容
#评价#
带量采购结果公布,过一致性评价药品命中率高,重点监控品种暂停交易
72
0
2018-11-15
回复
医者仁心
(审核中...)
关注
已关注
前往app查看评论内容
#评价#
不通过一致性评价注销批文?江苏药监**回应来了
53
0
2018-11-10
回复
huagfeg
(审核中...)
关注
已关注
前往app查看评论内容
#评价#
Sci Rep:建立三维胶原模型用于磁共振成骨的体外评价
48
0
2018-11-10
回复
huagfeg
(审核中...)
关注
已关注
前往app查看评论内容
#评价#
官方发文:未过一致性评价,注销批文!
84
0
2018-11-08
回复
huagfeg
(审核中...)
关注
已关注
前往app查看评论内容
#评价#
临床药物综合评价应优先开展
15
0
2018-11-07
回复
huagfeg
(审核中...)
关注
已关注
前往app查看评论内容
#评价#
Radiology:利用MR指纹识别评价内侧颞叶癫痫病灶的价值
97
0
2018-11-06
回复
huagfeg
(审核中...)
关注
已关注
前往app查看评论内容
#评价#
FDA仿制药一致性评价指导原则
91
0
2018-11-03
回复
huagfeg
(审核中...)
关注
已关注
前往app查看评论内容
#评价#
NMPA关于仿制药一致性评价的52个细节答疑
126
0
2018-11-03
回复
huagfeg
(审核中...)
关注
已关注
前往app查看评论内容
#评价#
NEJM:Hu5F9-G4和利妥昔单抗联合阻断非霍奇金淋巴瘤中CD47的疗效评价
72
0
2018-11-02
回复
huagfeg
(审核中...)
关注
已关注
前往app查看评论内容
#评价#
Anesth Analg:比较患者自控和医师控制丙泊酚镇痛的效果:系统评价和试验序贯的meta分析
71
0
2018-11-02
回复
huagfeg
(审核中...)
关注
已关注
前往app查看评论内容
#评价#
仿制药通过评价仅仅是补考及格,不要让一致性评价结果变味
62
0
2018-10-24
回复
huagfeg
(审核中...)
关注
已关注
前往app查看评论内容
#评价#
日本仿制药一致性评价,地震后行业巨大提升
72
0
2018-10-24
回复
huagfeg
(审核中...)
关注
已关注
前往app查看评论内容
#评价#
Surv Ophthalmol:系统评价营养补充对青光眼的辅助治疗疗效
76
0
2018-10-23
回复
huagfeg
(审核中...)
关注
已关注
前往app查看评论内容
#评价#
又一省发文,未过一致性评价不采购
73
0
2018-10-13
回复
huagfeg
(审核中...)
关注
已关注
前往app查看评论内容
#评价#
Int J Oral Max Surg:HIV阳性患者种植体存活情况的评价
58
0
2018-10-10
回复
huagfeg
(审核中...)
关注
已关注
前往app查看评论内容
#评价#
J Periodontol:腭黏膜移植术后使用氟比洛芬喷雾剂的效果评价
57
0
2018-10-07
回复
huagfeg
(审核中...)
关注
已关注
前往app查看评论内容
#评价#
一致性评价大限将至,新通知昨天出来了!
57
0
2018-10-02
回复
huagfeg
(审核中...)
关注
已关注
前往app查看评论内容
#评价#
碾压原研?过一致性评价仿制药还有这三道坎
72
0
2018-10-01
回复
huagfeg
(审核中...)
关注
已关注
前往app查看评论内容
#评价#
J Periodontol:家族性地中海热和慢性牙周炎患者唾液氧化应激的评价
63
0
2018-09-27
回复
huagfeg
(审核中...)
关注
已关注
前往app查看评论内容
#评价#
Daiichi宣布开展临床试验:评价其在研抗体偶联药物和Keytruda联合治疗乳腺癌和肺癌的药效
58
0
2018-09-25
回复
共500条
首页
上一页
下一页
尾页
页码:
18
/25页
20条/页
扫描二维码下载梅斯医学APP
科室
订阅+
更多科室
工具
服务